Emerg. Infect Dis 2001, 17: 178–182. 7. Stewart PS: Mechanisms of antibiotic resistance in bacterial biofilms. Int J Med Microbio 2002, 292: 107–113.CrossRef 8. Shirtliff ME, Mader JT, Camper AK: Molecular interactions in biofilms. Chem Biol 2002, 9: 859–865.PubMedCrossRef 9. Adam B, Baillie GS, Douglas LJ: Mixed species biofilms of Candida albicans and Staphylococcus epidermidis . J Med Microbiol 2002, 51: 344–349.PubMed 10. Wu JA, Kusuma C, Mond JJ, Kokai-Kun JF: Lysostaphin Disrupts Staphylococcus aureus and Staphylococcus epidermidis Biofilms on Artificial Surfaces. Antimicrob Agents Chemother

2003, 47: 3407–3414.PubMedCrossRef 11. Costerton J: Introduction to biofilm. Inter J Antimicro Agents 1999, 11: 217–221.CrossRef find more 12. Donlan RM, Costerton JW: Biofilms: survival mechanisms of see more clinically relevant microorganisms. Clin Microbiol Rev 2002, 15: 167–193.PubMedCrossRef 13. Yuan G, He G, Yang ML: Natural products and anti-inflammatory activity. Asia Pacific J Clin Nutrition 2006, 15: 143–152. 14. Kirtikar KR, Basu BD: In Indian Medicinal Plants. Volume I. 2nd edition. M/s Periodical Experts. Delhi, India; 1935:521. 15. Chatterjee GK, Pal SD: Anti-inflammatory agents from Indian medicinial Plants. Indian Drugs 1984, 21: 431. 16. Moore PD: Conservation biology: Unkind cuts for incense. Nature

CHIR 99021 2006, 444: 829.PubMedCrossRef 17. Singh S, Khajuria A, Taneja SC, Khajuria RK, Singh J, Qazi GN: Boswellic acids and glucosamine show synergistic effect in preclinical anti-inflammatory study in rats. Bioorg Med Chem Lett 2007, 17: 3706–3711.PubMedCrossRef 18. Safayhi H, Sailer ER, Ammon HP: Mechanism of 5-lipoxygenase inhibition by acetyl-11-keto-beta-boswellic acid. Mol Pharmacol 1995, 47: 1212–1216.PubMed 19. Safayhi Palmatine H, Rall B, Sailer ER, Ammon HP: Inhibition by boswellic acids of human leukocyte elastase. J Pharmacol Exp Ther 1997, 281: 460–463.PubMed 20. Krieglstein CF, Anthoni C, Rijcken EJ, Laukotter M, Spiegel HU, Boden SE, Schweizer

S, Safayhi H, Senninger N, Schurmann G: Acetyl-11-keto-beta-boswellic acid, a constituent of a herbal medicine from Boswellia serrata resin, attenuates experimental ileitis. Int J Colorectal Dis 2001, 16: 88–95.PubMedCrossRef 21. Gerhardt H, Seifert F, Buvari P, Vogelsang H, Repges R: Therapy of active Crohn disease with Boswellia serrata extract H 15. Z Gastroenterol 2001, 39: 11–17.PubMedCrossRef 22. Kimmatkar N, Thawani V, Hingorani L, Khiyani R: Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee–a randomized double blind placebo controlled trial. Phytomed 2003, 10: 3–7.CrossRef 23. Pardhy RS, Bhattacharya SC: Boswellic acid, acetyl- b-boswellic, acid-11- keto-b-boswellic acid and 11-keto-β-boswellic acids from the resin of Boswellia serrata Roxb. Ind J Chem 1978, 16B: 176–178. 24. Costerton J, Stewart P, Greenberg E: Bacterial biofilms: a common cause of persistent infections. Science 1999, 284: 1318–1322.PubMedCrossRef 25.